Treace Medical Concepts, Inc. Debt Securities, Available-for-sale, Amortized Cost
Treace Medical Concepts, Inc. (TMCI) had Debt Securities, Available-for-sale, Amortized Cost of $33.06 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $33.06M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $42.34M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $37.59M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $49.65M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $33.06M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $42.34M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $37.59M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $49.65M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $61.19M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $62.66M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $64.23M 10-K · filed 2026-02-27 |
| 2024-09-30 | $70.50M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $76.89M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $100.60M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $110.05M 10-K · filed 2025-02-27 |
| 2023-09-30 | $115.03M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $127.66M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $141.10M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $61.81M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |